Stocks and Investing Stocks and Investing
Fri, October 13, 2023
[ 12:00 AM ] - WOPRAI
Saul Martinez Initiated (V) at Hold and Held Target at $266 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (VSCO) at Hold and Held Target at $21 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Alexandra Steiger Maintained (VSCO) at Hold with Decreased Target to $16 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Saket Kalia Upgraded (VRNS) to Buy and Increased Target to $37 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (WBA) at Hold with Decreased Target to $26 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Patrick Wood Maintained (BLCO) at Hold with Decreased Target to $19 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Dan Levy Maintained (ADNT) at Buy with Decreased Target to $52 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Saul Martinez Initiated (AXP) at Strong Buy and Held Target at $181 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Timothy Thein Maintained (AGCO) at Strong Buy with Decreased Target to $150 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Javier Martinez Upgraded (AFYA) to Buy and Increased Target to $21 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (AKAM) at Hold with Increased Target to $102 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Timothy Thein Maintained (ALSN) at Hold with Increased Target to $65 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Quinn Bolton Upgraded (AMAT) to Strong Buy and Held Target at $180 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (AVY) at Strong Buy with Increased Target to $210 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Laura Chico Maintained (ATXS) at Buy with Decreased Target to $18 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Eric Wold Maintained (BC) at Strong Buy with Decreased Target to $97 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (BERY) at Strong Buy with Decreased Target to $71 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Mike Genovese Reiterated (CALX) at Strong Buy and Held Target at $70 on, Oct 13th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Grambling Maintained (BYD) at Hold with Decreased Target to $72 on, Oct 13th, 2023
Thu, October 12, 2023
[ 12:00 AM ] - WOPRAI
John Baumgartner Downgraded (BYND) to Sell and Held Target at $5 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Nigel Coe Downgraded (CARR) to Sell and Held Target at $56 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
John Lawrence Maintained (CASY) at Strong Buy with Increased Target to $312 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Lazar Maintained (BGS) at Hold with Decreased Target to $10 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Lincoln Kong Maintained (BILI) at Hold with Decreased Target to $17 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Mehdi Hosseini Maintained (ASML) at Buy with Decreased Target to $810 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Maintained (ATXS) at Strong Buy with Decreased Target to $18 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Noah Kaye Maintained (AMRC) at Buy with Decreased Target to $55 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Michael Yee Reiterated (AMGN) at Strong Buy and Held Target at $310 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
Fatima Boolani Maintained (AKAM) at Hold with Increased Target to $112 on, Oct 12th, 2023
[ 12:00 AM ] - WOPRAI
John Sourbeer Maintained (AKYA) at Strong Buy with Decreased Target to $7 on, Oct 12th, 2023

John Sourbeer Maintained (AKYA) at Strong Buy with Decreased Target to $7 on, Oct 12th, 2023


Published on 2024-10-28 06:52:12 - WOPRAI, John Sourbeer
  Print publication without navigation


John Sourbeer of UBS, Maintained "Akoya Biosciences, Inc." (AKYA) at Strong Buy with Decreased Target from $12 to $7 on, Oct 12th, 2023.

John has made no other calls on AKYA in the last 4 months.



There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with John's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with John

  • Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $16 on, Tuesday, August 8th, 2023
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $15 on, Tuesday, August 8th, 2023
Contributing Sources